Podcasts about Pill

In this episode, The Annuity Man discussed:  Recognizing annuity trade-offs Focusing on contractual guarantees Asking the right questions Evaluating strength over sales pitches   Key Takeaways:  No annuity is perfect; each comes with both benefits and limitations. They should be understood as commodity products rather than flawless solutions. Annuities should always be purchased for their contractual promises, such as lifetime income or principal protection, rather than hypothetical returns. The key to choosing the right annuity is identifying what you want the money to do contractually and when you want those guarantees to begin. When comparing annuities, focus on the company's financial stability and the highest contractual guarantees offered, not marketing claims or projections.   "If you do not need to contractually solve for one or more of those items in the PILL acronym, then you do not need an annuity." —  Stan The Annuity Man   Connect with The Annuity Man:  Website: http://theannuityman.com/  Email: Stan@TheAnnuityMan.com  Book: Owner's Manuals: https://www.stantheannuityman.com/how-do-annuities-work YouTube: https://www.youtube.com/channel/UCCXKKxvVslbeGAlEc5sra2g  Get a Quote Today: https://www.stantheannuityman.com/annuity-calculator!

We're hiring.  Apply now at POSHDJs.com

Are you taking hormone therapy but still struggling with symptoms like brain fog, fatigue, or sleepless nights? What if I told you that 50% of women are being under-treated with hormones, while 25% are getting too much—all because we're measuring the wrong things? In this groundbreaking episode, I reveal the shocking truth about why my hormone levels on paper might not match how I actually feel. I expose the critical gap between standard hormone testing and real therapeutic outcomes. This conversation is essential for any woman on hormone therapy who wants to optimize her treatment for both symptom relief and long-term protection of her brain, heart, and bones. What You'll Learn: • Why 50% of women are unknowingly under-treated with hormone therapy • The shocking 25% over-treatment rate using traditional symptom tracking • How absorption differences between women make standard dosing obsolete • The difference between symptom relief levels and brain-protective ranges • Why your patch, cream, or oil dose might be completely wrong for you • The three-step monitoring system that actually works • How liver metabolism affects your hormone effectiveness • The real therapeutic ranges that protect your long-term health   Ready to Transform Your Health? Stop guessing with your hormone therapy and start getting the results you deserve! Watch the full episode now to discover the personalized approach that's changing women's lives, subscribe for more evidence-based women's health content, and share this with every woman who's tired of settling for "good enough" hormone care. Links: Menrva Telemedicine: https://gethormonesnow.com/ - FREE Hormone Quiz: https://bit.ly/3wNJOec - Living Well Dallas: https://www.livingwelldallas.com/ - Hormone Reset: https://hormonereset.net/ - Betty Murray Website: https://www.bettymurray.com/ - Facebook: https://www.facebook.com/BettyAMurrayCN/ - Instagram: https://www.instagram.com/drbettymurray/   Connect with Dr. Betty Murray: - Website: https://www.bettymurray.com/ - Facebook: https://www.facebook.com/BettyAMurrayCN/ - Instagram: https://www.instagram.com/drbettymurray/   Thank you for listening to Menopause Mastery. Empowering your health journey, one episode at a time.

Are you taking hormone therapy but still struggling with symptoms like brain fog, fatigue, or sleepless nights? What if I told you that 50% of women are being under-treated with hormones, while 25% are getting too much—all because we're measuring the wrong things? In this groundbreaking episode, I reveal the shocking truth about why my hormone levels on paper might not match how I actually feel. I expose the critical gap between standard hormone testing and real therapeutic outcomes. This conversation is essential for any woman on hormone therapy who wants to optimize her treatment for both symptom relief and long-term protection of her brain, heart, and bones. What You'll Learn: • Why 50% of women are unknowingly under-treated with hormone therapy • The shocking 25% over-treatment rate using traditional symptom tracking • How absorption differences between women make standard dosing obsolete • The difference between symptom relief levels and brain-protective ranges • Why your patch, cream, or oil dose might be completely wrong for you • The three-step monitoring system that actually works • How liver metabolism affects your hormone effectiveness • The real therapeutic ranges that protect your long-term health   Ready to Transform Your Health? Stop guessing with your hormone therapy and start getting the results you deserve! Watch the full episode now to discover the personalized approach that's changing women's lives, subscribe for more evidence-based women's health content, and share this with every woman who's tired of settling for "good enough" hormone care. Links: Menrva Telemedicine: https://gethormonesnow.com/ - FREE Hormone Quiz: https://bit.ly/3wNJOec - Living Well Dallas: https://www.livingwelldallas.com/ - Hormone Reset: https://hormonereset.net/ - Betty Murray Website: https://www.bettymurray.com/ - Facebook: https://www.facebook.com/BettyAMurrayCN/ - Instagram: https://www.instagram.com/drbettymurray/   Connect with Dr. Betty Murray: - Website: https://www.bettymurray.com/ - Facebook: https://www.facebook.com/BettyAMurrayCN/ - Instagram: https://www.instagram.com/drbettymurray/   Thank you for listening to Menopause Mastery. Empowering your health journey, one episode at a time.

Send us a textNeste Pocket Pill, vamos direto ao ponto: HALT pós-TAVI. Explicamos o que é esse achado na tomografia, em quais pacientes vale a pena investigar e como conduzir a partir daí. Uma pílula rápida de conhecimento para clarear sua prática clínica.

Join us on the Fireside Chat as we speak with This is Shah, a men's advocate who speaks on dowry, child support and more!

Un édito aiguisé d'Arthur Chevallier, chaque matin à 7h20. Un parti-pris assumé sur une question d'actualité. D'accord ou pas, vous ne resterez pas indifférent. La chronique qui permet de réfléchir et aide à forger son opinion chaque matin du lundi au vendredi sur RMC et RMC Story.

09-03-25 - Rock Wars - Song For Brady When He Takes His Oxy PillSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

09-03-25 - Rock Wars - Song For Brady When He Takes His Oxy PillSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

09-02-25 - Entertainment Drill - TUE - Brady's Oxy Pill Has Kicked In And He Needs To GoSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

09-02-25 - Entertainment Drill - TUE - Brady's Oxy Pill Has Kicked In And He Needs To GoSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Matt explores the critical link between sleep and Alzheimer's disease today, explaining how the brain's "glymphatic system" clears toxic proteins like amyloid and tau during deep sleep. He describes how insufficient sleep impairs this process, creating a vicious cycle where protein accumulation damages sleep-generating brain regions and increases dementia risk.Matt goes on to discuss groundbreaking research on a new class of sleeping pills, Dual Orexin Receptor Antagonists (DORAs), that may enhance this cleaning mechanism. While preliminary human and animal studies show these drugs can reduce toxic proteins and offer neuroprotection, the findings underscore the profound importance of prioritizing high-quality sleep as a powerful, accessible tool for ensuring long-term brain health.Please note that Matt is not a medical doctor, and none of the content in this podcast should be considered medical advice in any way, shape, or form, nor prescriptive in any way.One of this week's sponsors, LMNT, offers a science-based electrolyte drink with no sugar or artificial ingredients. Try their new limited-time Lemonade Salt flavor, available May 20th! Get eight free sample packs with any order at drinklmnt.com/mattwalker. Stock up on this summer flavor while it lasts!Another sponsor, Shopify, made launching Matt's merchandise incredibly smooth with its integrated sales system. Shopify simplifies everything from online stores to in-person sales. Start your exclusive trial and see for yourself at shopify.com/mattwalker.In a supplement industry where trust is critical, Matt uses podcast partner Puori. Their protein powders are free from hormones, GMOs, and pesticides, with every single batch third-party tested for over 200 contaminants. For protein you can trust, save 20% at puori.com/mattwalker.As always, if you have thoughts or feedback you'd like to share, please reach out to Matt:Matt: Instagram @drmattwalker, X @sleepdiplomat, YouTube: https://www.youtube.com/channel/UCA3FB1fOtY4Vd8yqLaUvolg

It's Monday, September 1st, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus Muslims dress up as Christian cleric and choir members before killing In a chilling new tactic, Muslim rebels from the Allied Democratic Forces in Congo, Africa, disguised themselves as church officials and choristers before launching a recent fatal attack on Mayi Moya village in Beni Territory,  reports International Christian Concern. The Muslims killed three civilians and kidnapped eight. The attackers reportedly began their August 13 mission in Ngite village earlier in the morning, where they raided a church, stole clerical robes and choir garments, and posed as members of a religious delegation. One church official said, “They came into our church and stole the robes of our priests and choir; they then put them on, posing as a delegation from another church. It was a devilish plan. To use the very symbols of worship to deceive and destroy is beyond evil. My heart breaks for those who trusted them, thinking they came in peace.” When the group arrived in the village around 7:05 p.m., villagers welcomed them warmly, believing they were part of a church mission. Survivor Jean-Philip Mboosa recalled, “I thought initially that they genuinely were from a church. They greeted us with smiles and songs, and it looked so real. But when I went closer, I noticed guns hidden beneath the robes. That's when my heart sank. I knew we had been tricked. I walked quietly back and then ran into the bush, praying God would protect me.” In light of this story, Matthew 7:17 takes on a new connotation. “Beware of false prophets, who come to you in sheep's clothing, but inwardly they are ravening wolves.” President Trump fired Fed Reserve Board member Lisa Cook President Donald Trump fired Lisa Cook, a member of the board of governors for the U.S. Federal Reserve. In a post on Truth Social a week ago Monday, Trump cited a criminal referral presented to Attorney General Pam Bondi on August 15, alleging that Cook made “false statements on one or more mortgage agreements.” The president went on to say, “The American people must be able to have full confidence in the honesty of the members entrusted with setting policy and overseeing the Federal Reserve. In light of your deceitful and potentially criminal conduct in a financial matter, they cannot and I do not have such confidence in your integrity.”  Should Trump prevail in the legal case, his nominees would have the power to deliver Trump the rate cuts he has demanded.  Right now, the range is 4.2%-4.5%. The president would like to see the rate cut to 1%. CDC staff who Kennedy fired were promoting abortion After President Trump fired CDC Director Susan Monarez when she refused to resign, Health and Human Services Secretary Robert F. Kennedy Jr. defended the leadership overhaul at the Centers for Disease Control and Prevention in an August 29th interview on “Fox & Friends,” reports LifeNews.com. KENNEDY: “The CDC has problems. We saw the misinformation coming out of COVID. They got the testing wrong. They got the social distancing [wrong], the masks [wrong], the school closures that did so much harm to the American people. “Today, on CDC's website right now, they list the 10 greatest advances in medical science, and one of them is abortion, another is fluoridation, another is vaccines. “So, we need to look at the priorities of the agency. There's really a deeply, deeply embedded, I would say, malaise at the agency.  We need strong leadership that will go in there, and that will be able to execute on President Trump's broad ambitions.” While the CDC euphemistically references “family planning,” under its “Ten Great Public Health Achievements” of the 20th century, everyone knows that includes abortion as a morally acceptable decision for a pregnant mother. Christian baker who refused to make ‘wedding' cake for lesbians appeals to U.S. Supreme Court A devout Christian baker in California filed a request with the U.S. Supreme Court to protect her right to create custom-designed wedding cakes that reflect her faith, reports LifeSiteNews.com. Cathy Miller, owner of Cathy's Creations and Tastries in Bakersfield, California, has endured almost a decade of the state targeting her for her 2017 decision not to bake a cake for a lesbian faux “wedding” because of her Christian faith. MILLER: “In our standards, it says that I ‘cannot participate in a wedding that would be between a man and a man or a woman and a woman.' But I'll do their birthday cakes. I'll do their cookies, you know. And there's so many other bakeries that are happy to. I'm the only one in Bakersfield that said I can't participate in that union.” Genesis 2:24 says, “A man leaves his father and mother and is united to his wife, and they become one flesh.” Shockingly, within an hour of her polite refusal to make a wedding cake for a homosexual ceremony, the liberals tried to exact a pound of flesh. MILLER” “I said, you know, ‘I can't do your wedding cake. I can't create it for you, but I have someone who's a really good decorator, and I can refer you to her.' They got really upset. They grabbed the order form and they stormed out, and within an hour, there was a barrage of phone calls and threats. Social media just went nuts. “We received death threats, rape threats. I couldn't go anywhere except for the house, the bakery, and my church for three months. It was devastating to our family. It was devastating to the business.” One of Miller's employees also addressed the fallout. EMPLOYEE: “We had to shut down our emails. We had to shut down the phone calls. Only I or Kathy would answer them because they were very vulgar and threatening. They did break into Cathy's car and steal her computer and tried to damage the vehicle because it had a Tastries logo on it.” Miller added, “All I want is to serve my neighbors as the Gospel of Jesus Christ calls me to without being forced to create messages that violate my beliefs.” Texas House: If you send abortion kill pill, you'll be fined $100,000 And finally, the Texas House of Representatives passed a major pro-life bill last Thursday aimed at stopping mail-order abortion kill pills, reports LifeNews.com. The Woman and Child Protection Act  -- HB 7 sponsored by Sen. Bryan Hughes -- will head to the Senate for final approval this week. While abortion businesses are closing brick-and-mortar facilities, they are  shifting their tactics online. Activists send deadly pills into Texas illegally from other states and countries—to the tune of at least 19,000 orders of abortion drugs each year. Rep. Jeff Leach authored the measure. LEACH: “I am proud of this compassionate piece of legislation in front of you. This is going to save lives of baby boys and baby girls.” Democrat Texas Rep. Chris Turner, a pro-abort, asked Rep. Leach a question. TURNER: “Is your bill, House Bill 7, likely to increase or decrease women's fear of pregnancy in the state of Texas?” LEACH: “I am interested, by way of this bill, in protecting Texas babies and protecting their moms, and in building a culture of life here in the state of Texas. “Representative Turner, we should do everything we can to promote and elevate motherhood.” The Woman and Child Protection Act would do three things: First, allow Texans to shut down companies that sell abortion kill pills; Second, let women sue abortion kill pill traffickers; and And third, enable Texas to fine businesses which supply abortion drugs with a $100,000 fine. Close And that's The Worldview on this Monday, September 1st, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

This pill can kill without the woman knowing it. This pill can be mailed across state lines. This pill has already killed 500 million kids. . . soon to be 1 billion by 2030. Is this wrongful death or just plain murder? Chief responsibility for this holocaust lies at the feet of 4 people — all atheists and agnostics who turned away from the faith of their fathers. Will governments rein in the devastation, or will God have to do it?

A new MP3 sermon from Generations Radio is now available on SermonAudio with the following details: Title: The Pill that Took Over the World - 500 Million Kids Dead So Far Speaker: Kevin Swanson Broadcaster: Generations Radio Event: Radio Broadcast Date: 9/1/2025 Length: 36 min.

A new MP3 sermon from Generations Radio is now available on SermonAudio with the following details: Title: The Pill that Took Over the World - 500 Million Kids Dead So Far Speaker: Kevin Swanson Broadcaster: Generations Radio Event: Radio Broadcast Date: 9/1/2025 Length: 36 min.

A new MP3 sermon from The World View in 5 Minutes is now available on SermonAudio with the following details: Title: Texas House: If you send abortion kill pill, you’ll be fined $100,000 Subtitle: The World View in Five Minutes Speaker: Adam McManus Broadcaster: The World View in 5 Minutes Event: Current Events Date: 9/1/2025 Length: 9 min.

Treating recurrent miscarriages - with NaPro Dr. Susan Caldwell, fertility and infertility specialist, on Trending with Timmerie. (2:04) Why and how you should push back against physicians who prescribe birth control. What to say. (26:03) PMS questions (42:14) Resources mentioned: Dr. Susan Caldwell https://www.drsusancaldwell.com/ Previous Dr. Susan Caldwell episodes: https://relevantradio.com/?s=susan+caldwell Find a Creighton Fertility Care Instructor https://mycatholicdoctor.com/providers/fertility-educator/sl-creighton/ https://onemoresoul.com/category/contraception-abortion Book: Physicians Healed – One More Soul https://onemoresoul.com/featured/physicians-healed.html Episodes on why not take contraception? Contraception: Why Not? (catholiceducation.org) “Sex Au Natural” by Patrick Coffin https://www.amazon.com/Sex-Naturel-What-Good-Marriage/dp/1931018588 Dr. Lara Briden Period Repair Manual: https://www.larabriden.com/period-repair-manual/ Lara Briden – The Period Revolutionary Book Happy Girl’s Guide to Being Whole https://www.lumenpress.org/product/the-happy-girls-guide-to-being-whole/ Detoxing from the Pill https://relevantradio.com/2022/11/womens-health-fertility-with-dr-caldwell/

Sarah and Evan look at the tragic shooting in Minneapolis, the double standard on abortion drug usage, whether Spain is following the Fascist playbook, and the affects of AI chatbot companions.

The far more censored version of the award-winning and unparalleled "A Mediocre Time with Tom and Dan." - "A Corporate Time" is a daily companion and terrestrial radio show heard nationally on iHeartRadio. It's silly.

COVID-19 vaccine approvals; CDC leadership in turmoil; orforglipron weight loss trial results; Ixchiq license suspended by FDA; REMS updated for Filspari

Welcome to episode 226 of Growers Daily! We cover: playing a little “mulch matchmaker”, we get some specific winter killed cover crop scenarios broken down, AND pillbugs in the seed trays We are a Non-Profit! 

Shout out to all our members who make this content possible, sign up for only $5 a month    / @nojumper   Check out e420 app for deals Apple: https://spn.so/g6gbid5j Google: https://spn.so/104g2yp6 use code NOJUMPER for $$ off New episode of the No Jumper Show! Follow Adam22:   / adam22    / adam22    / adam22   adam22bro on Snapchat ----- Get the latest news & videos http://nojumper.com CHECK OUT OUR ONLINE STORE!!! https://shop.nojumper.com/ NO JUMPER PATREON   / nojumper   CHECK OUT OUR NEW SPOTIFY PLAYLIST https://open.spotify.com/playlist/5te... Follow us on SNAPCHAT   / 4874336901   Follow us on SPOTIFY: https://open.spotify.com/show/4z4yCTj... iTunes: https://itunes.apple.com/us/podcast/n... Follow us on Social Media:   / 4874336901    / nojumper    / nojumper    / nojumper    / nojumper   JOIN THE DISCORD:   / discord   Follow Adam22:   / adam22    / adam22    / adam22   adam22bro on Snapchat Learn more about your ad choices. Visit megaphone.fm/adchoices

The Food and Drug Administration approved the sale of over-the-counter birth control pills two years ago. The decision has dramatically increased access to contraception, according to a new study from Oregon Health & Science University.    Researchers found that more than a quarter of participants who were using the over-the-counter pill had switched from using no birth control at all. They also found that members of the over-the-counter group were more likely to be uninsured and live in rural areas than participants who used prescription birth control.   Maria Rodriguez is the director of both the Center for Reproductive Health Equity and the Center for Women’s Health at OHSU. She joins us with more on the importance of removing barriers to reproductive health care.  

Eli Lilly posted data Tuesday from a second Phase III trial of its oral weight loss therapy orforglipron, providing the company with all it needs to head to the FDA with a new drug application. For more in-depth discussion on the oral weight-loss space, check out a special episode of The Weekly. And stay tuned to BioSpace for more unique coverage of this market as we learn which investigational assets will make it across the regulatory finish line and which will join the weight-loss wasteland. On the business side of biopharma, AbbVie turned back to neuropsychiatric therapies this week, acquiring partner Gilgamesh Pharmaceuticals' lead depression candidate for $1.2 billion. The deal is a display of resilience for AbbVie in the neuropsychiatric space as well, after the stunning failure last November of schizophrenia asset emraclidine—picked up in its nearly $9 billion acquisition of Cerevel Therapeutics. And is the cooler late summer weather thawing the IPO market? Neuropsych-focused LB Pharma revealed in an SEC filing on Friday that it plans to take the plunge, ending a six-month stalemate in biotech IPOs.  Finally, the Department of Health and Human Services (HHS) has been busy this past week. On Monday, the CDC named Retsef Levi—a known vaccine critic—to head the agency's COVID-19 immunization working group, just as reports surfaced that the Trump administration could be “within months” of banning the COVID-19 vaccine in the U.S. Meanwhile, the FDA issued new draft guidance for cancer drug developers that prioritizes the use of survival data, and the agency began publishing drug-related adverse event reports daily.   HHS itself has also been the subject of recent headlines, announcing that it will no longer recognize employee unions, and last week, hundreds of HHS staffers penned an open letter calling on Secretary Kennedy to tone down what they called “dangerous and deceitful statements” that have fostered distrust against federal health workers, exposing them to physical harm. This followed the Aug. 8 shooting at CDC headquarters in Atlanta.   Finally, multinational pharmaceutical companies spent more than $48 billion on partnerships with China in the first half of 2025 alone, according to a new report from IQVIA—more than in all of 2024.  

Shout out to all our members who make this content possible, sign up for only $5 a month    / @nojumper   Check out e420 app for deals Apple: https://spn.so/g6gbid5j Google: https://spn.so/104g2yp6 use code NOJUMPER for $$ off New episode of the No Jumper Show! Follow Adam22:   / adam22    / adam22    / adam22   adam22bro on Snapchat ----- Get the latest news & videos http://nojumper.com CHECK OUT OUR ONLINE STORE!!! https://shop.nojumper.com/ NO JUMPER PATREON   / nojumper   CHECK OUT OUR NEW SPOTIFY PLAYLIST https://open.spotify.com/playlist/5te... Follow us on SNAPCHAT   / 4874336901   Follow us on SPOTIFY: https://open.spotify.com/show/4z4yCTj... iTunes: https://itunes.apple.com/us/podcast/n... Follow us on Social Media:   / 4874336901    / nojumper    / nojumper    / nojumper    / nojumper   JOIN THE DISCORD:   / discord   Follow Adam22:   / adam22    / adam22    / adam22   adam22bro on Snapchat Learn more about your ad choices. Visit megaphone.fm/adchoices

Might be a thing very soon.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As President Donald Trump pushes for a crime crackdown beyond Washington, DC, the House Oversight committee joins the DOJ to investigate the nation's capital. Trump has touted tariff revenue as debt-cutting, but there are some caveats. A new pill for weight loss could be one step closer to becoming a reality. How some kids will use AI in school this year. Plus, Southwest Airlines announced more new rules over seats Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, Elizabeth sits down with Dr. Jolene Brighten, hormone expert and author of Beyond the Pill and Is This Normal?, to discuss the truth about period pain, birth control, and endometriosis. Dr. Brighten shares her personal story of misdiagnosis, painful periods, and delayed endometriosis discovery, along with her mission to end medical gaslighting and give women the knowledge they deserve about their hormones.The conversation covers how birth control really works, what Post-Birth Control Syndrome is, and how to safely come off the pill while supporting your body. Dr. Brighten also breaks down the four phases of the menstrual cycle, how to spot red flags like hormonal acne, PMS, and PMDD, and offers powerful insight into how your cycle impacts your brain, energy, cravings, and mental health. The episode ends with a deep dive on endometriosis: signs, symptoms, testing options (like gel MRI), and why so many cases are overlooked or dismissed in the fertility space.Connect with Dr. Jolene Brighten:Instagram: @drjolenebrightenWebsite: drbrighten.comMentioned Free Resources:- Endometriosis Flare Guide: drbrighten.com/endoflare- ADHD/Hormone Sync Course: drbrighten.com/sync- Anti-Inflammatory Recipe Plan: drbrighten.com/planWatch the episode on YouTube:https://youtu.be/e16Ksh3WC4IFollow The Wellness Process:Instagram: @thewellnessprocesspodTikTok: @thewellnessprocesspodSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Stock market update for August 26, 2025.This video is for informational purposes only and reflects the views of the host and guest, not Public Holdings or its subsidiaries. Mentions of assets are not recommendations. Investing involves risk, including loss. Past performance does not guarantee future results. For full disclosures, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Public.com/disclosures⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

It's a big week for music on both sides of the Atlantic: in the UK, flagship music festival Reading and Leeds bookends the English music summer, while Canada is in the grips of Oasismania like never seen before. The Yellow Brit Road takes you inside Oasis' return to Toronto for the first time in 16 years, and we bring you our favourite picks of new artists playing Reading. Some new releases otherwise too, featuringOasis, Wolf Alice, Suede, High Vis, Jasmine.4.T, JD Cliffe, Keo, Mudi Sama, The Cliffords, VLURE, Sunday (1994), The Pill, The Jacques, SNAYX, Niki Kini, Glass Animals, Example, Still Woozy, Soft Play, Kate Nash.Find this week's YouTube playlist (live performances included) here. Thoughts on moving the playlist permanently off Spotify? Write in.Try and support artists independently through buying their music, merch, going to shows! Bandcamps/websites linked above.Touch that dial and tune in live! CFRC 101.9 FM in Kingston or cfrc.ca⁠, Sundays 8-9:30 PM! Full shows in the linked archive for 3 months from broadcast.Like what we do? ⁠Donate⁠ to help keep our 102-year old radio station going!Get in touch with the show: email ⁠yellowbritroad@gmail.com⁠, IG @⁠⁠yellowbritroad⁠⁠.PS: submissions, cc ⁠music@cfrc.ca⁠ if you'd like other CFRC DJs to spin your music on their shows as well.

In this first episode of The Hebrew Months Series with Rabbi Pill, we explore the unique energy of Elul, a month of teshuvah and alignment. Our sages teach that the months of the Jewish year are not just markers of time, but windows of opportunity, each with its own avodah and pathway for growth. Elul's symbols, the mazal of the Betulah (Maiden), the letter Yud, the tribe of Gad, the left hand, and the daily shofar blasts, each reveal how to realign with Hashem and our truest selves. But rather than seeing Elul as a season of guilt and repentance, Rabbi Pill reframes teshuvah as a return to alignment: uniting thought and action, living in the present moment, and even the surprising idea of “doing teshuvah on your teshuvah.” If you've heard the standard Elul messages before, this conversation will give you a fresh perspective, and practical ways to channel the energy of the month into lasting transformation.Join the Conversation! Be part of our growing community—join the Shema Podcast for the Perplexed WhatsApp group to share feedback, discuss episodes, and suggest future topics. Click here to sign up.Explore The Art of PrayerDownload a collection of beautifully designed blessings (brachos) including Modeh Ani, Asher Yatzar, Netilas Yadayim and more.  Free to download and perfect for your home by clicking here.Get the Companion Guide: The Power of the MonthsThis free resource outlines the spiritual focus of each Hebrew month — including its mazal (zodiac sign), tribe, Hebrew letter, body part, and unique avodah. It also includes suggested actions you can take to align yourself with the energy of the time. Click here to download and keep this month-by-month guide as a tool for your own growth and reflection.

The modern far right often play the underdogs, shaking fists at mysterious elites said to control our thoughts and culture. But much of their lexicon has already slipped into the mainstream. Phrases born on message boards now appear in newspapers, on TV, even in everyday chat. On today's Bunker, Dorian Lynskey talks to journalist Matt McManus, assistant professor at Spelman College and host of the Academic Edgelords podcast about the words and the warped worldview that the far right has smuggled into our politics. • We are sponsored by Indeed. Go to https://indeed.com/bunker for £100 sponsored credit.   www.patreon.com/bunkercast  Follow us on BlueSky: https://bsky.app/profile/bunkerpod.bsky.social  Advertisers! Want to reach smart, engaged, influential people with money to spend? (Yes, they do exist). Some 3.5 MILLION people download and watch our podcasts every month – and they love our shows. Why not get YOUR brand in front of our influential listeners with podcast advertising? Contact ads@podmasters.co.uk to find out more Written and presented by Dorian Lynskey. Producer: Liam Tait. Audio editor: Robin Leeburn. Managing editor: Jacob Jarvis. Music by Kenny Dickinson. Group Editor: Andrew Harrison. THE BUNKER is a Podmasters Production. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Gee Uno talks about Snoopy Badazz, Ant Jefe vs King Pill, PfaceBabyyy, and more. ----- Check out e420 app for deals Apple: https://spn.so/g6gbid5j Google: https://spn.so/104g2yp6 use code NOJUMPER for $$ off Shout out to all our members who make this content possible, sign up for only $5 a month    / @nojumper   Promote Your Music with No Jumper - https://nojumper.com/pages/promo CHECK OUT OUR ONLINE STORE!!! https://nojumper.com NO JUMPER PATREON   / nojumper   CHECK OUT OUR NEW SPOTIFY PLAYLIST https://open.spotify.com/playlist/5te... Follow us on SNAPCHAT   / 4874336901   Follow us on SPOTIFY: https://open.spotify.com/show/4z4yCTj... iTunes: https://itunes.apple.com/us/podcast/n... Follow us on Social Media:   / 4874336901    / nojumper    / nojumper    / nojumper    / nojumper   JOIN THE DISCORD:   / discord   Follow Adam22:   / adam22   adam22bro on Snapchat Learn more about your ad choices. Visit megaphone.fm/adchoices

Tech taking it on the chin, as big tech sells off in today's session. The Mag-7 names pulling down the space, and the semi stocks feeling the heat. Plus A biotech bummer. Shares of Viking Therapeutics tanking after the company posted disappointing weight loss drug pill trial data. What it means for the company's next move, and the impact it could have on potential M&A action.Fast Money Disclaimer

https://linktr.ee/manonthemounjaro

It's Monday, August 18th, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus Vietnamese Communists cut electricity to church mid-service As a Catholic priest quietly led a service in the home of one of 20 worshippers in the evening of August 11 in the Đại Từ district in northeast Vietnam, Communist authorities cut the home's electricity to stop the service, reports International Christian Concern. Then, they detained three church members. In John 15:18, Jesus said, “If the world hates you, keep in mind that it hated Me first.” Multiple worshippers livestreamed the arrests on Facebook. Within two hours, the video had been seen 60,000 times. After Putin-Trump meeting, Trump declared: “It's up to Zelenskyy” In a join press conference with U.S. President Donald Trump, Russian President Vladimir Putin summarized his perception of what needed to happen to end the Russo-Ukrainian War. He made the remarks following his 3-hour sit-down meeting with President Trump in Anchorage, Alaska last Friday.  Listen to the real-time translation by a female translator. PUTIN: “The situation in Ukraine has to do with fundamental threats to our security. Everything that's happening is a tragedy for us and terrible wound. Therefore, the country is sincerely interested in putting an end to it. “[At] the same time, we're convinced that in order to make the settlement lasting and long-term, we need to eliminate all the primary causes of that conflict. And we've said it multiple times, to consider all legitimate concerns of Russia and to reinstate a just balance of security in Europe and in the world on the whole. “Naturally, the security of Ukraine should be ensured as well. I would like to hope that the agreement that we've reached together will help us bring closer that goal and will pave the path towards peace in Ukraine.” Following the press conference, President Donald Trump talked to Sean Hannity on Fox News Channel. HANNITY: “If you had to grade it on a scale of one to 10?” TRUMP:  “I think the meeting was a ‘10' in the sense that we got along great. And it's good when, you know, two big powers get along, especially when they're nuclear powers. You know, we're number one, they're number two in the world.  That's a big deal. You never want to even mention that word, the word nuclear.” President Trump addressed how it went and what the next step is to bring the Russo-Ukrainian War to a close. TRUMP: “We were together almost three hours, and it was very extensive, and we agreed on a lot of points. I mean, a lot of points were agreed on, but there's not that much as you know, one or two pretty significant items, but I think they can be reached. Now, it's really up to [Ukrainian] President [Volodymyr] Zelenskyy to get it done.” Costco will not sell Abortion Kill Pill Costco Wholesale Corp. has announced it will not dispense the abortion kill pill mifepristone at its U.S. pharmacies, a decision hailed by pro-life advocates as a significant victory, reports LifeNews. The abortion kill pill has been responsible for killing millions of babies and killing and injuring countless women. The retail giant's decision comes amid pressure from Christian investors and pro-life groups urging major retailers to refrain from distributing the abortion drug. Costco has joined other major retailers like Walmart, Kroger, and Albertsons, which have also declined to sell the deadly pills. Send a 2-sentence thank you note to Ron Vachris, Costco President, 999 Lake Drive, Issaquah, Washington 98027. Massachusetts is Sanctuary state for transgender surgery on kids Massachusetts has become a “sanctuary state” for transgender procedures on children, report MassResistance. Shockingly, Massachusetts doctors who break other states' laws prohibiting transgender procedures will be protected from prosecution -- and their names hidden from the public.  While 25 states have banned such foolishness, the Massachusetts Legislature passed the so-called “shield law” on July 31, 2025. It is among the most aggressive and offensive anti-family laws anywhere in America. Days later, the state's radical lesbian Democratic Governor Maura Healy, who is in a sinful relationship with Joanna Lydgate, signed it into law. Dr. Elizabeth Boskey at Boston Children's Hospital revealed the hospital is willing to remove a 15-year-old girl's healthy breasts. BOSKEY: “The eligibility for getting gender-affirming surgeries at Boston Children's Hospital is basically the same as it would be for most other hospitals or surgeons in the United States. And that's the case because we all follow the World Professional Association for Transgender Health standards of care. “For top surgery, you are requested,  but not required, to have been on gender-affirming hormones for at least a year. If you're a ‘trans woman,' it's really encouraged that you be on estrogen for at least a year, because you want to maximize your natural breast growth. “Many surgical centers require you to be 18. At Boston Children's Hospital, for top surgeries, we'll see people as young as age 15, if they've been affirmed in their gender for a long period of time and don't really have any other life complications that make surgery inappropriate.” 41 Planned Parenthood abortion mills have closed this year Ready for some great news? So far this year, the Planned Parenthood abortion business has closed 41 centers. Despite what the abortion giant and the media would have Americans think, they all participated in abortions, reports Life News. William Carey, father of modern missions, said,  And finally, 264 years ago yesterday, a very special man was born in England. William Carey is his name and he is known as the "father of modern missions.” The eldest of five children, his parents were weavers.  Carey went to work for the local shoemaker, Thomas Old, during which time he taught himself Hebrew, Italian, Dutch, and French. He often read while working on the shoes. Carey married Old's sister-in-law, Dorothy Plackett, with whom he had seven children. Sadly, three of their kids died before the age of five. Inspired by Jonathan Edwards' An account of the life of the Rev. David Brainerd,  Carey spent 41 years in India as a missionary without a furlough.  He led 700 souls to Christ in a nation of millions.  Romans 10:15 says, “How beautiful are the feet of those who preach the good news!” He wrote a book entitled An Enquiry into the Obligations of Christians to Use Means for the Conversion of the Heathens which led to the founding of the Baptist Missionary Society. Carey was known for saying, “Expect great things from God; attempt great things for God."   He also said, "To know the will of God, we need an open Bible and an open map." He understood the importance of both Scripture and understanding the world around us. Finally, he prioritized meaningful work. He said, “I'm not afraid of failure; I'm afraid of succeeding at things that do not matter." Close And that's The Worldview on this Monday, August 18th, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

Jules from Grey Pilled hits Paranoi Radio with scripture, philosophy, and forbidden conspiracies. From underwater secrets to interdimensional shadows, he rips through the fabric of belief and reality. This is the Grey Pill—raw, unfiltered, and aimed straight at the lies they feed you.GREY PILLED PATREONXYOUTUBERUMBLE// Paranoi Radio is on YouTube

Cody joins Sarah and Evan as we look at the possibility of Obergefell being revisited by the Supreme Court, Pete Hegseth's retweeting about the 19th Amendment, whether Sydney Sweeney's ad really is eugenic, Trump's Smithsonian overhaul, the Good Samaritan vs. DEI, and a trio of articles about Nigerian Christians. Links to all articles: https://everymancommentary.substack.com/p/im-confusedso-genes-dont-matter-anymorehttps://abcnews.go.com/Politics/supreme-court-formally-asked-overturn-landmark-same-sex/story?id=124465302https://abcnews.go.com/US/wireStory/hegseth-reposts-video-social-media-featuring-pastors-women-124496930https://everymancommentary.substack.com/p/the-good-samaritan-vs-dei?r=jkwx1https://www.christianpost.com/voices/how-the-prosperity-gospel-has-driven-nigerian-christians-away.htmlhttps://www.christianpost.com/news/over-7k-christians-killed-in-nigeria-so-far-in-2025-watchdog.htmlhttps://www.christianpost.com/news/nigerian-anglicans-cut-ties-with-wales-church-over-lesbian-bishop.htmlhttps://www.politico.com/news/2025/08/12/smithsonian-museums-trump-review-00505838

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

The drug maker Merck recently announced its plans to start two new trials, known as the EXPrESSIVE program, testing a monthly pill for PrEP. A once-a-month PrEP pill holds great potential for the field. Even with daily pills, a monthly ring, or long acting injectables such as cabotegravir and recently FDA-approved lenacapavir, there'll be people who can't find what they really need for prevention.    For advocates who follow prevention, there's a lot to know about these trials, and powerful lessons to learn about Good Participatory Practice (GPP) and impactful involvement of stakeholders—especially community—in research. GPP has been a cornerstone of the process of design and protocol development for the EXPrESSIVE trials, and it doesn't stop there.   This episode features Merck Senior Principal Scientist Rebeca Plank and AVAC's Regional Manager for Research Engagement Grace Kumwenda. They explain why a monthly pill could be so important to HIV prevention and how GPP is shaping the design and rollout of the trials. 

"I wasn't gonna let him win"It's December 27th, 2021, and young police officer Ashley Ferris reluctantly accepts an overtime shift— not knowing that this decision will change her life forever. That night, a supposed "Alpha" male & manosphere podcaster known as Lyndon McLeod begins his terrifying revenge spree in downtown Denver, acting out his murderous hit list hidden in the pages of his novel, "Sanction". In the dark winter night, no one knows where he will strike next, nor how to stop his rampage...Unless Ashley, who feels she has nothing to lose, can find the dangerous gunman and put a stop to his reign of terror, at any cost.Ashley's non-profit, A Fighting Chance:https://www.afightingchanceltd.com/ Alicia Cardenas: https://www.gofundme.com/f/support-for-Cardenas-family?utm_campaign=p_cp+share-sheet&utm_medium=copy_link_all&utm_source=customer Jimmy Maldonado: https://www.gofundme.com/f/support-soltribe-shooting-survivor-in-healing-transition?fbclid=PAZXh0bgNhZW0CMTEAAafT-nKZoA1aY47kWcgLKB2ZbvIk8tWD4FmWIBbqKeH4uBYLqm3qgB0KU2Yenw_aem_vJpcz97L05EMAehJnLxmVg Sarah Steck: https://www.gofundme.com/f/help-sarahs-family-with-this-tragedy Danny Scofield: https://www.gofundme.com/f/danny-dano-blair-scofield?utm_medium=referral&utm_source=unknown&utm_campaign=comms_drx8+danny-dano-blair-scofield Ashley Ferris https://www.gofundme.com/f/qfugzz-help-our-friends-recovery?utm_medium=referral&utm_source=unknown&utm_campaign=comms_drx8+qfugzz-help-our-friends-recovery Alyssa: https://www.groundingdown.com/alyssa-gunn-maldonado-fund Credits:Written, directed & edited by Alexandre GendronResearched by Manon LafosseVoiceover by William AkanaProduced by Alexandra Salois & Salim SaderSources: “Control, Alt, Delete”. Deadly Influence: The Social Media Murders: Warner Bros Discovery Inc. 2023. (Talos Films / Investigation Discovery)Podcasts:“Behind the Badge: A Story of Hope with Ashley Ferris”. From Survivor to Thriver: Erik Da Rosa and Marc Fernandes, 2023. “Stay in the fight”. The muster room: Eric Potts and Austin Glickman / Joseph Ryder, 2023. “Courage, Hope and Resilience” The Danny and Park Novels Good News Podcast, 2024. “Denver's Tumultuous Tattoo History, In Alicia Cardenas's Own Words”. City Cast Denver, 2025.“Alicia Cardenas, Denver, CO Full Length” The Nature Of Refuge. 2018.Denver 7 - ABCFox 319NewsCBS ColoradoKCAL NewsCBS NewsDW NewsCBS MiamiNBC NewsBBCABC News HLNInside EditionABC 7BBC 3 Scripps NewsCNNSky NewsABC News in depthNBC New-YorkKGTVOthers (YouTube. Podcasts, TV & Articles)The Glitch GlobalThe M PodThe LiverKingHow To Beast talksReal Talk with Zuby - boogiebuttersLogocentrifugal 74Thiccoq ProductionsAlpha IntellectWarhorse, Lyndon McLeod, 2021Andrew Tate's Best Quotes, KingTok, 2022Masculinity Motivational Advice, The Glitch Global, 2024The Disturbing Downfall Of The Liver King, Kavos, 2025FreshAndFit's Double Standards For Women, Annamarie Forcino, 2021Andrew Tate vs Piers Morgan, Piers Morgan Uncensored, 2022He Murdered 5 People. But Before Then, He Made a Movie About It., VICE, 2022Andrew Tate Inspired Him to ‘Come Out of His Shell', Dr. Phil, 2023FITXFEARLESSCoffeehouse CrimeThe 'Incel' Movement: How It May Have Motivated Toronto Van Attack, Inside Edition, 2018Woman shares footage of assault by street harasser at Paris cafe, The Guardian, 2018This Is What The Life Of An Incel Looks Like, VICE, 2018What Is Toxic Masculinity?, Pop Culture Detective, 2016Fight Club, 20th Century Fox, 1999Joker, Warner Bros. Pictures, 2019The Red Pill, Gravitas Ventures, 2016Adolescence, Netflix, 2025The Matrix, Warner Bros., 1999Jimmy Maldonado, Wolf and Goat Tattoolyslas, Instagramcorazon_de_tecpatl, Instagramafightingchanceltd, InstagramAlicia Cardenas, FacebookSanction I, Roman McClay, 2019Sanction II, Roman McClay, 2019Sanction III, Roman McClay, 2020Getty Images

A ubiquitous feature in Jewish homes, the Mezuzah contains a scroll with two paragraphs from the Torah, one from this week's Parsha and one from last week's. This mitzvah bears a distinction that it shares with no other mitzvah. In this interesting and useful podcast, we explore the secrets represented by the Mezuzah, and learn […]

A ubiquitous feature in Jewish homes, the Mezuzah contains a scroll with two paragraphs from the Torah, one from this week's Parsha and one from last week's. This mitzvah bears a distinction that it shares with no other mitzvah. In this interesting and useful podcast, we explore the secrets represented by the Mezuzah, and learn how it can serve as a panacea - a pill of longevity.– – – – – – – – – – – – – – – – – – – – – –DONATE: Please consider supporting the podcasts by making a donation to help fund our Jewish outreach and educational efforts at https://www.torchweb.org/support.php. Thank you!– – – – – – – – – – – – – – – – – – – – – –Email me with questions, comments, and feedback: rabbiwolbe@gmail.com– – – – – – – – – – – – – – – – – – – – – –SUBSCRIBE to my Newsletterrabbiwolbe.com/newsletter– – – – – – – – – – – – – – – – – – – – – –SUBSCRIBE to Rabbi Yaakov Wolbe's PodcastsThe Parsha PodcastThe Jewish History PodcastThe Mitzvah Podcast This Jewish LifeThe Ethics PodcastTORAH 101   ★ Support this podcast ★

Today's Headlines: We're ending the week on a truly chaotic note. Texas Senator John Cornyn got the FBI involved to help track down state Democrats who fled to avoid a rushed redistricting vote—one that would give Republicans five extra seats, just because Trump said they should have them. Trump's also pushing for early redistricting in other red states and floated a new census that would exclude undocumented immigrants—never mind what the Constitution says. In other news, he signed an order demanding colleges hand over race-based admissions data, and the Air Force is cutting off early retirement benefits for transgender service members. Additionally, Trump now wants your 401(k) to dabble in crypto and real estate, and he's nominating an aide to the Fed who's big on lowering interest rates. Finally, Apple CEO Tim Cook gave Trump a weird gold iPhone trophy, VP JD Vance's river was allegedly raised for his birthday kayak trip, Israel confirmed it plans to take full control of Gaza, and Eli Lilly released promising results from a study of its new weight loss pill. Resources/Articles mentioned in this episode: NBC News: Sen. John Cornyn says the FBI granted his request to help find absent Texas Democrats WaPo: Led by Trump, Republicans push to redraw election maps in multiple states Axios: Trump says he's ordering a new census. Here's what the Constitution says Axios: Trump orders colleges to report race data AP News: Trump's Air Force denies retirement pay to ex-trans service members Axios: Trump to supercharge private equity with 401(k) order PBS: Trump says he is nominating top economic aide Stephen Miran to Federal Reserve board The Verge: Apple made a 24k gold and glass statue for Donald Trump AP News: JD Vance went kayaking for his birthday. Secret Service had the river level raised AP News: Netanyahu says Israel plans to take over Gaza to destroy Hamas Wired: Eli Lilly's Obesity Pill Shows Promising Weight Loss in New Results Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

See omnystudio.com/listener for privacy information.

Gotta have one.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

BACKONFIGG EP:299 Big Sad 1900 Addresses Wack 100, T-Money & King Pill, New Music + More! Learn more about your ad choices. Visit megaphone.fm/adchoices

Shout out to all our members who make this content possible, sign up for only $5 a month    / @nojumper   Promote Your Music with No Jumper - https://nojumper.com/pages/promo CHECK OUT OUR ONLINE STORE!!! https://nojumper.com NO JUMPER PATREON   / nojumper   CHECK OUT OUR NEW SPOTIFY PLAYLIST https://open.spotify.com/playlist/5te... Follow us on SNAPCHAT   / 4874336901   Follow us on SPOTIFY: https://open.spotify.com/show/4z4yCTj... iTunes: https://itunes.apple.com/us/podcast/n... Follow us on Social Media:   / 4874336901    / nojumper    / nojumper    / nojumper    / nojumper   JOIN THE DISCORD:   / discord   Follow Adam22:   / adam22   adam22bro on Snapchat Learn more about your ad choices. Visit megaphone.fm/adchoices